Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Resuscitation | 2 | 2005 | 59 | 0.330 |
Why?
|
| Abdominal Injuries | 2 | 2006 | 35 | 0.300 |
Why?
|
| Abdominal Muscles | 3 | 1996 | 7 | 0.270 |
Why?
|
| Physical Examination | 2 | 2006 | 53 | 0.260 |
Why?
|
| Ultrasonography | 2 | 2006 | 243 | 0.250 |
Why?
|
| Brain Injuries | 1 | 2006 | 50 | 0.250 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 14 | 0.230 |
Why?
|
| Traumatology | 1 | 2005 | 20 | 0.230 |
Why?
|
| Thoracic Wall | 1 | 2004 | 11 | 0.210 |
Why?
|
| Absorbable Implants | 1 | 2004 | 16 | 0.210 |
Why?
|
| Pediatrics | 1 | 2005 | 92 | 0.210 |
Why?
|
| Polyglycolic Acid | 1 | 2004 | 38 | 0.210 |
Why?
|
| Emergency Service, Hospital | 1 | 2005 | 122 | 0.210 |
Why?
|
| Hernia, Inguinal | 1 | 2023 | 6 | 0.210 |
Why?
|
| Lactic Acid | 1 | 2004 | 94 | 0.200 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2004 | 72 | 0.200 |
Why?
|
| Polymers | 1 | 2004 | 118 | 0.200 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 191 | 0.190 |
Why?
|
| Laparoscopy | 1 | 2023 | 156 | 0.180 |
Why?
|
| Retrospective Studies | 6 | 2023 | 2635 | 0.150 |
Why?
|
| Child | 5 | 2006 | 2291 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 30 | 0.120 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1995 | 2 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 1996 | 94 | 0.110 |
Why?
|
| Antibodies | 1 | 1995 | 125 | 0.110 |
Why?
|
| Fluid Therapy | 1 | 1994 | 14 | 0.110 |
Why?
|
| Burns | 1 | 1994 | 17 | 0.100 |
Why?
|
| Infant | 3 | 2004 | 1025 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2005 | 2426 | 0.070 |
Why?
|
| Humans | 9 | 2006 | 28870 | 0.070 |
Why?
|
| Glasgow Coma Scale | 1 | 2006 | 22 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2004 | 916 | 0.060 |
Why?
|
| Comorbidity | 1 | 2006 | 261 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 485 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2005 | 27 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2005 | 131 | 0.060 |
Why?
|
| Registries | 1 | 2006 | 397 | 0.050 |
Why?
|
| Granuloma, Giant Cell | 1 | 2004 | 3 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2005 | 125 | 0.050 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2004 | 10 | 0.050 |
Why?
|
| Thoracic Neoplasms | 1 | 2004 | 9 | 0.050 |
Why?
|
| General Surgery | 1 | 2005 | 63 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 787 | 0.050 |
Why?
|
| Sarcoma | 1 | 2004 | 29 | 0.050 |
Why?
|
| Gorilla gorilla | 1 | 2023 | 7 | 0.050 |
Why?
|
| Herniorrhaphy | 1 | 2023 | 17 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 303 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 194 | 0.050 |
Why?
|
| Male | 4 | 2023 | 13931 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 347 | 0.040 |
Why?
|
| Hypertension | 1 | 2003 | 309 | 0.040 |
Why?
|
| Female | 3 | 2023 | 15631 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 634 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 10699 | 0.030 |
Why?
|
| Partial Pressure | 1 | 1996 | 4 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2004 | 1173 | 0.030 |
Why?
|
| Mortality | 1 | 1996 | 46 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 1996 | 42 | 0.030 |
Why?
|
| Iowa | 1 | 1995 | 3 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 1995 | 4 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 1995 | 19 | 0.030 |
Why?
|
| Chickens | 1 | 1995 | 62 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 133 | 0.030 |
Why?
|
| Antibody Formation | 1 | 1995 | 77 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 147 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 278 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 1994 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 465 | 0.030 |
Why?
|
| Base Sequence | 1 | 1995 | 589 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1995 | 202 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 697 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1995 | 515 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 1056 | 0.020 |
Why?
|
| Oklahoma | 1 | 1995 | 1053 | 0.020 |
Why?
|
| Adult | 1 | 2004 | 8026 | 0.020 |
Why?
|
| Mice | 1 | 1995 | 4808 | 0.010 |
Why?
|
| Emergencies | 1 | 2004 | 28 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 102 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 202 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 221 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 247 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 524 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 554 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 737 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 481 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 1280 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 1588 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 3194 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1995 | 5 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1995 | 68 | 0.010 |
Why?
|
| Reoperation | 1 | 1995 | 153 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 1032 | 0.010 |
Why?
|
| Quality of Life | 1 | 1995 | 521 | 0.010 |
Why?
|